← stocks-llm Find companies like PFE →

Pfizer (PFE)

Health Care · Integrated biopharmaceuticals (prescription drugs and vaccines)

Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular, and infectious disease.

What Pfizer does

Pfizer discovers, develops, manufactures, and distributes biopharmaceutical products including prescription medicines and vaccines. The company operates two main segments: Biopharma (innovative medicines for oncology, immunology, vaccines, and other therapeutic areas) and CentreOne (contract manufacturing and pharmaceutical services). Pfizer markets products across developed and emerging markets worldwide, serving patients through healthcare providers and government programs.

Themes: ["mRNA vaccines","COVID-19 pandemic response","cardiovascular disease","oncology","immunology","vaccines and immunization","infectious disease","primary care"]

Fundamentals

Dividend: yield +7.1%; 5-year non-decreasing per-share dividend streak (SEC XBRL).

Ask why PFE looks like this →

Key risks (from latest filing)

["Revenue concentration and decline in COVID-19 product sales (Comirnaty and Paxlovid) as pandemic demand normalizes","Regulatory and pricing pressure from government programs including Medicare Drug Price Negotiation Program and Inflation Reduction Act","Patent expirations and generic/biosimilar competition for key revenue-generating products"]

See PFE's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.